Trevena Inc (TRVN)
0.409
+0.03
(+7.35%)
USD |
NASDAQ |
Apr 25, 16:00
0.4099
0.00 (0.00%)
Pre-Market: 09:22
Trevena Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -4.41K% |
| June 30, 2023 | -265.2% |
| March 31, 2023 | -130.3K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -81.94K% |
| December 31, 2021 | |
| September 30, 2021 | -7.61K% |
| June 30, 2021 | -7.88K% |
| March 31, 2021 | -4.71K% |
| December 31, 2020 | -17.20K% |
| September 30, 2020 | -185.0% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -20.79K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -3.44K% |
| September 30, 2018 | -149.4% |
| June 30, 2018 | -372.2% |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | -1.02K% |
| March 31, 2016 | -948.2% |
| December 31, 2015 | -824.7% |
| September 30, 2015 | -566.2% |
| June 30, 2015 | -614.3% |
| March 31, 2015 | -2.07K% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -4.99K% |
| March 31, 2013 | -7.00K% |
| December 31, 2012 | -1.23K% |
| September 30, 2012 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-130.3K%
Minimum
Mar 2023
-185.0%
Maximum
Sep 2020
-27.53K%
Average
-7.74K%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -641.0% |
| Return on Assets | -95.21% |
| Return on Invested Capital | -151.5% |
| Return on Net Operating Assets | -415.3% |